Form 4: Natera CFO Michael Brophy Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Natera's Chief Financial Officer, Michael Brophy, sold a portion of his shares to cover tax obligations related to vesting restricted stock units.
Summary
- Michael Brophy, the Chief Financial Officer of Natera, Inc., engaged in multiple transactions involving the company's common stock.
- On January 22, 2025, 1,250 restricted stock units (RSUs) vested, which were converted into common stock.
- To cover tax obligations associated with the vesting of these RSUs, Mr. Brophy sold 495 shares on January 23, 2025, at a price of $171.09 per share.
- Additionally, on January 24, 2025, he sold 687 shares at $171.80 per share and 259 shares at $172.4405 per share.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2023.
- Following these transactions, Mr. Brophy directly owns 109,474 shares of Natera common stock and 3,750 restricted stock units.
Sentiment
Score: 5
Explanation: The document reflects routine transactions related to executive compensation and tax obligations. There is no indication of positive or negative sentiment.
Risks
- Executive stock sales, even for tax purposes, can sometimes be perceived negatively by the market, potentially impacting investor sentiment.
Industry Context
Executive stock sales are a common occurrence, especially around vesting periods. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- Many executives at publicly traded companies use 10b5-1 trading plans to manage their stock sales, particularly around vesting events.
- The sale of shares to cover tax obligations is a common practice among executives who receive equity compensation.
- Comparable companies in the biotech and diagnostics space also see similar patterns of executive stock transactions.
Stakeholder Impact
- The stock sales may have a minor impact on the overall share price, but are unlikely to significantly affect long-term stakeholders.
Key Dates
| Date | Description |
|---|---|
| 01/22/2025 | 1,250 Restricted Stock Units vested. |
| 01/23/2025 | 495 shares of common stock sold at $171.09 per share. |
| 01/24/2025 | 687 shares of common stock sold at $171.80 per share and 259 shares sold at $172.4405 per share. |
Keywords
Natera, NTRA, Michael Brophy, CFO, stock sale, restricted stock units, Rule 10b5-1, insider trading, tax obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.